Cheng J Q, Lee W C, Klein M A, Cheng G Z, Jhanwar S C, Testa J R
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Genes Chromosomes Cancer. 1999 Mar;24(3):238-42.
We previously reported NF2 mutations in malignant mesothelioma (MM) cell lines and corresponding primary tumors. We have now generated polyclonal antibodies that specifically recognize the C-terminus of the NF2 protein. Western blot analysis was performed on 25 MM cell lines, 14 of which showed no NF2 expression. Single-strand conformation polymorphism and DNA sequence analyses revealed NF2 mutations in each of these 14 cell lines. To explore the mechanism of inactivation of NF2, loss of heterozygosity analysis was performed with two microsatellite markers located in the vicinity of the NF2 locus in chromosome band 22q12. Eighteen of the 25 cell lines (72%) showed losses at one or both loci tested. All cases exhibiting mutation and/or aberrant expression of NF2 showed allelic losses, suggesting that inactivation of NF2 in MM occurs via a two-hit mechanism.
我们之前报道过恶性间皮瘤(MM)细胞系及相应原发性肿瘤中存在NF2突变。我们现已制备出能特异性识别NF2蛋白C端的多克隆抗体。对25个MM细胞系进行了蛋白质免疫印迹分析,其中14个未显示NF2表达。单链构象多态性和DNA序列分析揭示这14个细胞系均存在NF2突变。为探究NF2失活的机制,使用位于22q12染色体带NF2基因座附近的两个微卫星标记进行杂合性缺失分析。25个细胞系中有18个(72%)在一个或两个检测位点出现缺失。所有显示NF2突变和/或异常表达的病例均出现等位基因缺失,提示MM中NF2的失活是通过双打击机制发生的。